Literature DB >> 12874409

Mutations in the epsilon-sarcoglycan gene found to be uncommon in seven myoclonus-dystonia families.

F Han1, A E Lang, L Racacho, D E Bulman, D A Grimes.   

Abstract

Myoclonus-dystonia syndrome (MDS) is a disorder for which the major cause appears to be mutations in the epsilon-sarcoglycan gene (SGCE). The authors have now performed mutation screening in 22 affected individuals from seven families with findings of typical MDS. A novel 5-bp deletion in exon 7 of the gene in one family and the previously reported R102X nonsense mutation in exon 3 in two other families were identified. Mutations in the SGCE gene were found in the minority of families screened in this series.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874409     DOI: 10.1212/01.wnl.0000073142.40185.c1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes.

Authors:  S Tezenas du Montcel; F Clot; M Vidailhet; E Roze; P Damier; C P Jedynak; A Camuzat; A Lagueny; L Vercueil; D Doummar; L Guyant-Maréchal; J-L Houeto; G Ponsot; S Thobois; M-A Cournelle; A Durr; F Durif; B Echenne; D Hannequin; C Tranchant; A Brice
Journal:  J Med Genet       Date:  2005-10-14       Impact factor: 6.318

2.  A Japanese family with dystonia due to a pathogenic variant in SGCE.

Authors:  Takuya Morikawa; Shiroh Miura; Luoming Fan; Emina Watanabe; Ryuta Fujioka; Hiromichi Motooka; Shingo Yasumoto; Yusuke Uchiyama; Hiroki Shibata
Journal:  Hum Genome Var       Date:  2022-08-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.